| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Gene Loss of Function MutationDepartment of Internal Medicine (E.P.S., R.M.C.), Division of Endocrinology, Diabetes and Metabolism, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267; South Dakota State University (B.S.), Ethel Austin Martin Program in Human Nutrition, Brookings, South Dakota 57007; Division of Endocrinology (B.E.B., M.J.A.), Childrens Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229; Laboratory of Reproductive and Developmental Toxicology (K.S.Ki., K.S.Ko.), National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; Department of Hematology and Oncology (K.S.Ki.), Emory University School of Medicine, Atlanta, Georgia 30322; Womens Health & Musculoskeletal Biology (X.J.L.), Wyeth Research, Cambridge, Massachusetts 02140; National Institute of Dental and Craniofacial Research (M.F.Y.), Bethesda, Maryland 20892; Department of Medicine (N.S.F.), Johns Hopkins University, Baltimore, Maryland 21224; Division of Pediatric Endocrinology (G.R.F.), Schneider Childrens Hospital/Long Island Jewish Medical Center, New Hyde Park, New York 11042; and Department of Biochemistry & Child Health (D.B.L.), University of Missouri, Columbia, Missouri 65211
Address all correspondence and requests for reprints to: Eric P. Smith, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Cincinnati College of Medicine, Vontz Center for Molecular Studies, 3125 Eden Avenue, Cincinnati, Ohio 45267-0547. E-mail: smithep{at}email.uc.edu.
Context: The kindred described is the only known instance of a germ line loss of function mutation of estrogen receptor (ER)-
.
Objective: Our objective was to assess the impact of a loss of function mutation in the ER-
gene on histomorphometry, bone volumetric density, bone geometry and skeletal growth, and ER-
heterozygosity on spine density and adult height in an extended pedigree.
Design and Participants: A longitudinal follow-up of the propositus with homozygous loss of function mutation of ER-
and single contact evaluation of the kindred were performed.
Main Outcome Measures: Iliac crest bone biopsy and peripheral quantitative computed tomography of propositus with serial measures of areal spine bone mineral density (aBMD) by dual-energy x-ray absorptiometry and bone age were performed. Members of pedigree were evaluated for ER-
mutation carrier status and spine aBMD.
Results: Bone biopsy revealed marked osteopenia (cortex: 641 µm), low trabecular volume (10.6%), decreased thickness (76.2 µm), normal trabecular number, and low activation frequency (0.099/yr). Radial periosteal circumference was similar, endosteal circumference larger, and trabecular and cortical volumetric bone mineral density markedly lower (158 and 1092 mg/cm3, respectively) than controls. Spine aBMD at age 28.5 yr (0.745 g/cm2) decreased to 0.684 g/cm2 (Z score –3.85) in 3.5 yr. Bone age advanced from 15–17.5 yr. Kindred analysis revealed that gene carriers had spine aBMD Z scores less than zero (P = 0.003), but carriers and nonmutant members were similar (–0.84 ± 0.26 vs. –0.64 ± 0.16).
Conclusion: Homozygous ER-
disruption markedly affects bone growth, mineral content, and structure but not periosteal circumference. ER-
heterozygosity appears to not impair spine aBMD.
This article has been cited by other articles:
![]() |
B. Lapauw, Y. Taes, S. Goemaere, K. Toye, H.-G. Zmierczak, and J.-M. Kaufman Anthropometric and Skeletal Phenotype in Men with Idiopathic Osteoporosis and Their Sons Is Consistent with Deficient Estrogen Action during Maturation J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4300 - 4308. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Callewaert, K. Venken, J. Ophoff, K. De Gendt, A. Torcasio, G. H. van Lenthe, H. Van Oosterwyck, S. Boonen, R. Bouillon, G. Verhoeven, et al. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-{alpha} FASEB J, January 1, 2009; 23(1): 232 - 240. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |